![Behind The Study v1](https://www.oncotarget.net/wp-content/uploads/2020/12/Behind-The-Study-v1-300x157.png)
Behind the Study: New Clues for Targeting Drug Resistant Colon Cancers
March 8, 2021
Dr. Bruce Boman from the Helen F. Graham Cancer Center describes the findings in a study he helped author in Oncotarget titled, "The anti-cancer effect of retinoic acid signaling in... read more